文献速递消化系统肿瘤

转移性结直肠癌的理性治疗:人、小鼠与培养皿的反向叙事

Rational Treatment of Metastatic Colorectal Cancer: A Reverse Tale of Men, Mice, and Culture Dishes.
PubMed 文献 · Cancer Discov · 2021-04-05

本文综述患者来源的临床前模型(可扩增的 patient-derived 肿瘤样本)在结直肠癌分层治疗中的作用。这类模型帮助功能验证生物标志物与疗效的关联,发现新的疗效决定因素、治疗靶点及肿瘤适应与耐药机制,并讨论其结果解读与临床转化的挑战。

要点

  • 患者来源模型可功能验证结直肠癌疗效生物标志物的因果作用。
  • 此类模型有助于发现新可操作靶点及肿瘤进化适应与耐药机制。
  • 需关注患者来源模型结果的解读与临床转化可行性挑战。

核心结论

  • 患者来源的结直肠癌模型通过提供临床相关实验背景,有助于阐明生物标志物对药物敏感性的因果作用,并揭示新靶点、肿瘤进化适应动态及耐药机制。

研究设计与样本

  • 综述类文章,围绕可扩增的患者来源肿瘤样本建立的临床前模型展开讨论。

主要发现

  • 基于可扩增患者来源样本的临床前模型增进了对结直肠癌疾病生物学的理解。
  • 此类模型促进了关联信息的功能验证,并助力发现新的疗效决定因素、治疗靶点及肿瘤适应与耐药机制。
  • 结直肠癌患者中的关联研究已识别出疗效生物标志物,部分已作为治疗决策的伴随诊断实施。

临床怎么用

  • 患者来源模型可用于功能验证结直肠癌疗效生物标志物,辅助治疗决策相关的生物学研究。
  • 综述强调需关注此类模型结果解读与临床转化可行性的新兴挑战。

局限性

  • 患者来源模型所得结果的解读与临床转化可行性仍面临挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stratification of colorectal cancer into subgroups with different response to therapy was initially guided by descriptive associations between specific biomarkers and treatment outcome. Recently, preclinical models based on propagatable patient-derived tumor samples have yielded an improved understanding of disease biology, which has facilitated the functional validation of correlative information and the discovery of novel response determinants, therapeutic targets, and mechanisms of tumor adaptation and drug resistance. We review the contribution of patient-derived models to advancing colorectal cancer characterization, discuss their influence on clinical decision-making, and highlight emerging challenges in the interpretation and clinical transferability of results obtainable with such approaches. SIGNIFICANCE: Association studies in patients with colorectal cancer have led to the identification of response biomarkers, some of which have been implemented as companion diagnostics for therapeutic decisions. By enabling biological investigation in a clinically relevant experimental context, patient-derived colorectal cancer models have proved useful to examine the causal role of such biomarkers in dictating drug sensitivity and are providing fresh knowledge on new actionable targets, dynamics of tumor evolution and adaptation, and mechanisms of drug resistance.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Avolio M, Trusolino L. Rational Treatment of Metastatic Colorectal Cancer: A Reverse Tale of Men, Mice, and Culture Dishes. Cancer Discov. 2021. PMID: 33820776. doi:10.1158/2159-8290.CD-20-1531

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。